In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming Labor Day holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and international clients.

A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by detecting key mast cell mediators.

Today's highlights include: Pandemic gets tougher to track as COVID testing plunges, Rochester hospitals score top grades in safety, and Mayo Clinic breaks ground on $155M Minnesota hospital expansion.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for a leadership update with Bobbi Pritt, M.D. This week, Dr. Morice and Dr. Pritt talk about the importance of collaboration between laboratory professionals and other members of the patient care team, and they discuss the crucial role lab medicine plays in the clinical practice.

As Mayo Clinic’s Anatomic Pathology moves from traditional glass slides to digital images, the advance in technology is achieving clear benefits in collaboration, learning, and patient care.

Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories' unique approach to urine drug testing for addiction rehabilitation. Designed to guide and monitor therapy, the comprehensive profile tests for the most commonly used substances, including alcohol and nicotine, for a complete picture of a patient’s substance use.

Top highlights include: Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.

Topics include: Hepatitis in children: What parents need to know, and FDA limits use of J&J COVID-19 vaccine.

Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Jorge Torres-Mora, M.D., assistant professor of Laboratory Medicine and Pathology at Mayo Clinic, to discuss the importance of integrating molecular information into your anatomic pathology practice.

Due to the Memorial Day holiday (recognized on Monday, May 30), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan ahead.

In April 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for a leadership update with Bobbi Pritt, M.D. This week, Dr. Morice and Dr. Pritt discuss government regulation and oversight of lab developed tests, and review proposed legislation that would affect clinical laboratories.

A pioneering researcher, Dr. Vanda Lennon has spent five decades delving into questions of neuroimmunology. Today, she continues that work as director of the Neuroimmunology Research Laboratory in Mayo Clinic’s Department of Laboratory Medicine and Pathology.